Search Within

Sunitha Bai Thakur

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. GSK Faculty (7)
  2. Human Oncology and Pathogenesis Program (7)
  3. Medical Physics (7)
  4. Tow Center for Developmental Oncology (TCDO) (7)
  5. Neuroradiology Service (5)
  6. Radiology, Department of (5)

More Groups

People
  1. Ingo Mellinghoff (7)
  2. Robert Young (5)
  3. Marc Rosenblum (3)
  4. Alexandra Miller (2)
  5. Andrei Holodny (2)
  6. Andrew Lin (2)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (2)
  5. 2016 (1)
  6. 2015 (1)
Publications
  1. Neuro-Oncology (4)
  2. Cancer Research (1)
  3. European Journal of Nuclear Medicine and Molecular Imaging (1)
  4. Journal of Clinical Oncology (1)
Publishers
  1. Oxford University Press (4)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Non-invasive diagnosis of IDH-mutant brainstem gliomas
    Meeting Abstract

    Kushnirsky, M.; Thakur, S.; Karajannis, M.; Bale, T.; Rosenblum, M.; Malani, R.; Gavrilovic, I. T.; Schaff, L.; Pentsova, E.; Grommes, C.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • 18F-fluoroglutamine PET as a promising prognostic tool in IDH mutant glioma
    Meeting Abstract

    Krebs, S.; Graham, M. S.; Grkovski, M.; Mauguen, A.; Goel, R.; Thakur, S. B.; Schaff, L. R.; Mellinghoff, I. K.; Young, R. J.; Kaley, T.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in Recurrent IDH1 mutant, low-grade glioma: Updated results
    Meeting Abstract

    Mellinghoff, I.; Cloughesy, T.; Wen, P.; Taylor, J.; Maher, E.; Arrillaga-Romany, I.; Peters, K.; Choi, C.; Ellingson, B.; Lin, A.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • A phase I, open label, perioperative study of AG-120 and AG-881 in recurrent IDH1 mutant, low-grade glioma: Results from cohort 1
    Meeting Abstract

    Mellinghoff, I. K.; Cloughesy, T. F.; Wen, P. Y.; Taylor, J. W.; Maher, E. A.; Arrillaga, I.; Peters, K. B.; Choi, C. H.; Ellingson, B. M.; Lin, A. P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
    Journal Article

    de la Fuente, M. I.; Young, R. J.; Rubel, J.; Rosenblum, M.; Tisnado, J.; Briggs, S.; Arevalo-Perez, J.; Cross, J. R.; Campos, C.; Straley, K.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Feasibility of 2-hydroxyglutarate 1H-MR spectroscopy for routine clinical glioma imaging
    Meeting Abstract

    de la Fuente, M. I.; Young, R.; Rubel, J.; Tisnado, J.; Briggs, S.; Holodny, A. I.; Deasy, J.; DeAngelis, L. M.; Cross, J.; Mellinghoff, I. K.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save